Annual report pursuant to Section 13 and 15(d)

Note 23 - Quarterly Financial Data (Unaudited)

v3.20.4
Note 23 - Quarterly Financial Data (Unaudited)
12 Months Ended
Dec. 31, 2020
Notes to Financial Statements  
Quarterly Financial Information [Text Block]

NOTE 23.     QUARTERLY FINANCIAL DATA (UNAUDITED)

 

The following table sets forth certain unaudited quarterly financial data derived from our consolidated financial statements. Such data is only a summary and should be read in conjunction with our historical consolidated financial statements and related notes continued in this annual report on Form 10-K.

 

   

2020 Quarter Ended

 
   

(Dollars in thousands, except per share data)

 
   

March 31

   

June 30

   

September 30

   

December 31

 

Interest income

  $ 96,767     $ 95,080     $ 96,110     $ 101,065  

Interest expense

    19,127       11,846       11,028       8,984  

Net interest income

    77,640       83,234       85,082       92,081  

Provision for credit losses (1)

    13,584       10,283       12,284       6,283  

Net income available to common stockholders

    34,778       40,417       43,362       50,949  

Net income per common share, basic

  $ 0.65     $ 0.75     $ 0.80     $ 0.94  

Net income per common share, diluted

  $ 0.64     $ 0.75     $ 0.80     $ 0.94  

 

   

2019 Quarter Ended

 
   

(Dollars in thousands, except per share data)

 
   

March 31

   

June 30

   

September 30

   

December 31

 

Interest income

  $ 93,699     $ 97,787     $ 101,130     $ 98,187  

Interest expense

    24,921       27,702       28,125       22,410  

Net interest income

    68,778       70,085       73,005       75,777  

Provision for credit losses (1)

    4,885       4,884       6,985       5,884  

Net income available to common stockholders

    35,010       35,602       37,563       41,005  

Net income per common share, basic

  $ 0.65     $ 0.67     $ 0.70     $ 0.77  

Net income per common share, diluted

  $ 0.65     $ 0.66     $ 0.69     $ 0.76  

 

(1) The first three quarters of 2020 and all of 2019 were estimated and recorded under the incurred loss methodology and not restated for the adoption of ASC 326. The Company elected to delay the adoption of CECL as allowed under the CARES Act.